Neuropathology

2.0k papers and 29.5k indexed citations i.

About

The 2.0k papers published in Neuropathology in the last decades have received a total of 29.5k indexed citations. Papers published in Neuropathology usually cover Neurology (760 papers), Molecular Biology (612 papers) and Genetics (441 papers) specifically the topics of Glioma Diagnosis and Treatment (360 papers), Parkinson's Disease Mechanisms and Treatments (274 papers) and Alzheimer's disease research and treatments (247 papers). The most active scholars publishing in Neuropathology are Mari Yoshida, Hitoshi Takahashi, Koichi Wakabayashi, Masahito Yamada, Seung Up Kim, Takaaki Kirino, Hiroaki Miyajima, Renpei Sengoku, Fumiaki Mori and Hiroko Ohgaki.

In The Last Decade

Fields of papers published in Neuropathology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Neuropathology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Neuropathology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Neuropathology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Neuropathology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025